Heidi Health is a technology company.
Heidi Health has raised $88.0M across 3 funding rounds.
Heidi Health has raised $88.0M in total across 3 funding rounds.
Heidi Health has raised $88.0M in total across 3 funding rounds.
Heidi Health's investors include Blackbird Ventures Australia, Taylor Brandt, Headline (formerly e.ventures), Point72 Ventures.
Heidi Health is an Australian health technology company founded in 2019 that develops an AI-powered medical scribe platform to automate clinical documentation.[2][3][6] The product transcribes patient consultations in over 110 languages, generates structured notes, referral letters, patient summaries, and follow-up materials, while integrating with major EHR systems like Epic, Athenahealth, and MedicalDirector to reduce clinician burnout and administrative burden.[1][2][3][6] It serves healthcare professionals across more than 200 medical specialties—including doctors, nurses, psychologists, dietitians, and veterinarians—handling over two million patient consults weekly and returning over eight million hours annually to clinicians for direct patient care.[1][6] With $26 million raised to date and a recent $65 million funding round, Heidi demonstrates strong growth momentum, earning high user satisfaction (100% of KLAS surveyed customers would repurchase) amid expanding global adoption.[3][6][8]
Heidi Health originated in 2019 when vascular surgical resident Dr. Thomas Kelly, alongside co-founders Waleed Mussa and Yu Liu, launched the company initially as Oscer, a platform for clinical training tools aimed at healthcare professionals.[2][3] The idea stemmed from Kelly's firsthand experience with documentation overload in clinical settings, prompting a pivot in 2021 to rebrand as Heidi Health and focus on AI-driven medical scribing to transcribe consultations and produce notes without interrupting patient interactions.[1][2] Early traction built through real-world testing across specialties, leading to rapid international expansion, enterprise-grade security certifications (SOC 2 Type II, ISO 27001, HIPAA, GDPR), and backing from global investors, including a landmark $65 million raise to fuel global scaling.[3][6][8]
Heidi Health rides the ambient AI in healthcare trend, addressing clinician burnout from administrative tasks amid global workforce shortages and rising patient volumes.[1][6] Timing aligns with post-pandemic demand for productivity tools, as AI scribes like Heidi automate 70-80% of documentation, enabling focus on care in primary, specialty, and telehealth settings.[2][4] Market forces favoring it include regulatory support for AI (e.g., NHS priorities for workforce efficiency), explosive growth in digital health funding, and competition from tools like Nuance Dragon but with Heidi's edge in multi-language, multi-specialty support and proven scale (e.g., largest clinical AI rollouts).[3][4][8] It influences the ecosystem by setting benchmarks for secure, clinician-trusted AI, fostering adoption in public systems like the NHS Midlands cohort and driving broader AI integration to enhance capacity without sacrificing human elements.[1][4][6]
Heidi Health is poised for accelerated global dominance in AI clinical documentation, leveraging its $65M war chest for deeper EHR integrations, expanded billing/coding automation, and penetration into underserved markets like Europe and Asia.[6][7][8] Trends like multimodal AI (voice + vision) and value-based care will amplify its role, potentially doubling clinician capacity as adoption hits enterprise scale, though refining integrations remains key to sustaining 100% repurchase rates.[2][5][6] Its evolution from training tool to indispensable partner underscores a trajectory of transformative impact, restoring humanity to overburdened healthcare one consult at a time—echoing its mission to make care steadily more connected and human.[1]
Heidi Health has raised $88.0M across 3 funding rounds. Most recently, it raised $65.0M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $65.0M Series B | Blackbird Ventures Australia, Taylor Brandt, Headline (formerly e.ventures), Point72 Ventures | |
| Mar 1, 2025 | $17.0M Series A | Blackbird Ventures Australia, Taylor Brandt, Headline (formerly e.ventures), Point72 Ventures | |
| Oct 1, 2023 | $6.0M Series A | Blackbird Ventures Australia, Taylor Brandt, Point72 Ventures |